5VM
SKYE icon

5AM Venture Management’s Skye Bioscience SKYE Stock Holding History

5AM Venture Management’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.95M Hold
9,681,763
– – 1.65% 18
2025
Q4 		$7.26M Hold
9,681,763
– – 2.28% 18
2025
Q3 		$38M Sell
9,681,763
-231,405
-2% -$874K 13.94% 1
2025
Q2 		$41.4M Hold
9,913,168
– – 15.93% 1
2025
Q1 		$15.8M Hold
9,913,168
– – 5.96% 4
2024
Q4 		$28.1M Hold
9,913,168
– – 6.69% 3
2024
Q3 		$38.8M Sell
9,913,168
-266,337
-3% -$1.49M 8.01% 3
2024
Q2 		$81.5M Buy
+10,179,505
New +$121M 18.24% 1

Other funds holding SKYE

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

5AM Venture Management's SKYE Position: Q1 2026 in Review

5AM Venture Management held its Skye Bioscience (SKYE) position steady in Q1 2026 at 9,681,763 shares worth $5.95M. The position accounts for 1.65% of the portfolio, ranked #18.

5AM Venture Management first reported a position in SKYE in Q2 2024 and has held it in 8 quarters since. The position peaked at $81.5M in Q2 2024. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • 5AM Venture Management held 9,681,763 shares of Skye Bioscience worth $5.95M as of Q1 2026.
  • 5AM Venture Management left its Skye Bioscience share count unchanged in Q1 2026.
  • Skye Bioscience made up 1.65% of 5AM Venture Management's portfolio in Q1 2026, its #18 holding.
  • 5AM Venture Management first reported a position in Skye Bioscience in Q2 2024 and has held it in 8 quarters since.
  • 5AM Venture Management's Skye Bioscience position peaked at $81.5M in Q2 2024.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on 5AM Venture Management's 13F filing for Q1 2026, filed 15 May 2026.